Clinical Trial Update: Biomarker Development for Response Prediction by DNA Mutational Analysis

View source ↗

Summary

A terminated clinical trial update on developing a DNA mutational biomarker to predict treatment response in metastatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: P.O. Witteveen | Conditions: Neoplasm Metastasis | Status: TERMINATED